Compare CAQ & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAQ | NREF |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.9M | 296.5M |
| IPO Year | 2026 | N/A |
| Metric | CAQ | NREF |
|---|---|---|
| Price | $9.94 | $16.19 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 8.8K | ★ 77.6K |
| Earning Date | N/A | 04-30-2026 |
| Dividend Yield | N/A | ★ 13.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.47 |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $12.36 |
| 52 Week High | $9.97 | $16.18 |
| Indicator | CAQ | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 57.89 | 61.84 |
| Support Level | N/A | $14.45 |
| Resistance Level | $9.97 | N/A |
| Average True Range (ATR) | 0.01 | 0.32 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 57.14 | 98.05 |
Cambridge Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.